Abbott Diagnostics Technologies AS is a Norwegian AS based in Oslo, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 1999, the company has 285 employees and reported revenue of NOK 1.7bn in its latest annual filing.
Industri, handel og annen virksomhet som angår disse formål, samt å delta i andre selskap eller foretak med lignende formål, og alt hva som står i forbindelse med dette.
In its most recent annual report (2025), Abbott Diagnostics Technologies AS reported revenue of NOK 1.7bn, a decrease of 13% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of NOK 118.9m, and the EBITDA margin stood at 10.2%.
At the end of 2025, equity financed 50.3% of the balance sheet, and current assets covered short-term debt 1 times.
Frequently asked questions
What is the Org number of Abbott Diagnostics Technologies AS?
Abbott Diagnostics Technologies AS is registered with Brønnøysundsregistrene under Org 981363019.
What is the revenue of Abbott Diagnostics Technologies AS?
Abbott Diagnostics Technologies AS reported revenue of NOK 1.7bn in 2025.
How many employees does Abbott Diagnostics Technologies AS have?
Abbott Diagnostics Technologies AS employs 285 people as of the latest annual report.
Who is the CEO of Abbott Diagnostics Technologies AS?
Line Røed is the CEO of Abbott Diagnostics Technologies AS, in role since 2025.
Who is the chairman of Abbott Diagnostics Technologies AS?
Oddvar Arne Vanberg chairs the board of Abbott Diagnostics Technologies AS, in role since 2018.
Where is Abbott Diagnostics Technologies AS headquartered?
Abbott Diagnostics Technologies AS's registered address is Kjelsåsveien 161.
